Macrogen, Inc. announced that it has obtained export approval for COVID-19 test kit AxenTM COVID-19 RT from the Ministry of Food and Drug Safety. Earlier, Macrogen collected samples from the upper and lower airway of COVID-19 patients, and conducted a clinical trial with its test kit AxenTM COVID-19 RT. Macrogen confirmed 100% consistency in 20 samples each in the positive and negative groups and reported these results to the MFDS. Macrogen applied various guidelines including a Draft International Standard by the International Organization for Standardization's technical committees of medical devices, and completed its self-development of the test kit AxenTM COVID-19 RT. Currently, Macrogen is preparing to obtain Emergency Use Authorization from the U.S. FDA and Europe's CE In-Vitro Diagnostics. These authorizations are expected to increase Macrogen's exports across the U.S. and Europe as well as Brazil and Uruguay, in which the test kit is currently under negotiation.